GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024
Welcome back to the final installment of our three-part miniseries on Primary Biliary Cholangitis (PBC) from the GHAPP National 2024 Conference! In this episode, Elizabeth Goacher, FNP, Jeremy Davis, ...
18 Loka 20242min
GHAPP PBC Podcast Series Part 1: Prevalence, Awareness and Identification of PBC
Welcome to Part 1 of our three-part miniseries on Primary Biliary Cholangitis (PBC), recorded live at GHAPP 2024! In this episode, Elizabeth Goacher, FNP (Duke University), Jeremy Davis, NP (Gastroint...
18 Loka 20243min
GHAPP PBC Podcast Series Part 2: New Therapeutics In The PBC Space
Welcome back to Part 2 of our three-part Primary Biliary Cholangitis (PBC) miniseries, where we explore the latest advancements in PBC treatment and disease management. In this episode, Elizabeth Goac...
18 Loka 20245min
KOL Conversation: New & Emerging Treatment Considerations for PBC & PBC Pruritus
In this episode, Jordan Mayberry, PA-C from UT Southwestern Medical Center, discusses how newly approved therapies are transforming the management of cholestatic pruritus in Primary Biliary Cholangiti...
15 Loka 20241min
KOL Conversation: A New Treatment Option
Live from the GHAPP 2024 Conference in Washington, D.C., Dr. Renee Pozza, NP (Southern California GI & Liver Centers) and Allysa Saggese, NP (Weill Cornell Medicine, Manhattan) discuss the latest FDA-...
15 Loka 20249min
Medication Review: What is the clinical profile of Resmetirom, including dosing schedules?
Thank you to Madrigal for your support of this Medication Review Video Module.In this Medication Review Video Module, Whitney Steinmetz, NP, provides an in-depth discussion on the clinical profile of ...
3 Loka 20242min
FAQ: How is MASH severity staged? What would an ideal MASH NIT algorithm look like?
Thank you to Madrigal for your support of this FAQ Video Module.In this FAQ Video Module, Jonathan Yeh, PA, from Columbia University Irving Medical Center, discusses the evolution of Metabolic Dysfunc...
3 Loka 20242min
FAQ: What are the consequences of NASH going untreated?
Thank you to Madrigal for your support of this FAQ Video Module.In this FAQ Video Module, Corrie Berk, NP, Director of Hepatology and Transplant Outreach Programs at the Texas Liver Institute, discuss...
3 Loka 20243min
